Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.670
-0.090 (-1.89%)
At close: Aug 10, 2026, 4:00 PM EDT
4.580
-0.090 (-1.93%)
After-hours: Aug 10, 2026, 7:34 PM EDT

Treace Medical Concepts Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-59.52-59-55.74-49.53-42.82-20.55
Depreciation & Amortization
8.3710.628.425.352.130.69
Stock-Based Compensation
30.0533.8230.617.358.113.41
Other Adjustments
5.717.174.991.997.730.25
Change in Receivables
1.11-2.09-5.69-9.3-11.04-4.23
Changes in Inventories
2.863.22-10.01-9.85-8.77-2.74
Changes in Accounts Payable
-3.9-3.8-1.313.174.611.79
Changes in Accrued Expenses
2.52-2.41-7.97.537.136.61
Changes in Other Operating Activities
-4.52-3.51-0.52-1.292.26-2.42
Operating Cash Flow
-14.58-15.97-37.17-34.58-30.65-17.19
Operating Cash Flow Growth
------
Capital Expenditures
-10.47-13.52-11.59-11.46-14.84-2.71
Purchases of Investments
-28.99-40.57-71.58-169.87-63.41-
Proceeds from Sale of Investments
57.1267.34118.55120.021.73-
Cash Acquisitions
----20--
Investing Cash Flow
17.6513.2535.38-81.3-76.52-2.71
Short-Term Debt Issued
----3.85-
Short-Term Debt Repaid
------1.79
Net Short-Term Debt Issued (Repaid)
----3.85-1.79
Long-Term Debt Issued
-59.31--49.65-
Long-Term Debt Repaid
--56.32---33.89-
Net Long-Term Debt Issued (Repaid)
-3--15.76-
Issuance of Common Stock
0.410.550.43109.42.19109.44
Repurchase of Common Stock
-0.72-0.9-0.27-0.01--
Net Common Stock Issued (Repurchased)
-0.31-0.360.16109.382.19109.44
Other Financing Activities
-1.21-0.56---0.99-
Financing Cash Flow
1.482.080.16109.3820.81107.65
Net Cash Flow
4.56-0.64-1.63-6.49-86.3687.75
Free Cash Flow
-25.05-29.49-48.76-46.03-45.49-19.9
Free Cash Flow Growth
------
FCF Margin
-12.20%-13.86%-23.29%-24.60%-32.07%-21.07%
Free Cash Flow Per Share
-0.39-0.47-0.79-0.76-0.82-0.41
Levered Free Cash Flow
-64.65-65.4-78.66-56.08-30.68-21.31
Unlevered Free Cash Flow
-58.86-63.54-78.61-57.98-42.32-15.29
SEC Filings: 10-K · 10-Q